We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Vail Resorts
MTN
$5.54B
| $8.17M | 0.03% |
36,593
+2,124
| +6% | +$472K |
|
552
Trimble
TRMB
$13.5B
| $8.09M | 0.03% |
179,431
+10,441
| +6% | +$434K |
|
553
i3 Verticals
IIIV
$424M
| $8.05M | 0.03% |
+273,477
| New | +$6.77M |
|
|
DCPH
554
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.99M | 0.03% |
354,503
+46,371
| +15% | +$1.09M |
|
555
Idacorp
IDA
$8.22B
| $7.99M | 0.03% |
79,556
+48,860
| +159% | +$4.93M |
|
556
Norwegian Cruise Line
NCLH
$9.63B
| $7.99M | 0.03% |
148,896
+8,647
| +6% | +$481K |
|
557
Neurocrine Biosciences
NBIX
$18.2B
| $7.96M | 0.03% |
94,304
+36,477
| +63% | +$3M |
|
558
Cheesecake Factory
CAKE
$4.35B
| $7.93M | 0.03% |
+181,400
| New | +$8.47M |
|
559
SolarEdge
SEDG
$2.31B
| $7.78M | 0.03% |
+124,542
| New | +$6.28M |
|
560
Magnolia Oil & Gas
MGY
$5.59B
| $7.66M | 0.02% |
+661,593
| New | +$8.11M |
|
561
Jacobs Solutions
J
$16.5B
| $7.48M | 0.02% |
107,122
-701,620
| -87% | -$45.3M |
|
|
FLNT
562
Fluent
FLNT
$104M
| $7.43M | 0.02% |
+230,179
| New | +$8.11M |
|
563
PagerDuty
PD
$802M
| $7.43M | 0.02% |
+157,887
| New | +$7.67M |
|
|
SYNH
564
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $7.33M | 0.02% |
143,514
-107,041
| -43% | -$4.98M |
|
565
BioMarin Pharmaceuticals
BMRN
$11.9B
| $7.32M | 0.02% |
85,448
-23,307
| -21% | -$1.99M |
|
|
ABMD
566
DELISTED
Abiomed Inc
ABMD
| $7.26M | 0.02% |
27,869
+11,317
| +68% | +$3M |
|
567
TSMC
TSM
$2.02T
| $7.24M | 0.02% |
184,833
-82
| -0% | -$3.38K |
|
568
SLM Corp
SLM
$4.77B
| $7.21M | 0.02% |
742,159
+43,184
| +6% | +$428K |
|
569
Freshpet
FRPT
$3.04B
| $7.15M | 0.02% |
157,058
+7,058
| +5% | +$320K |
|
570
Turning Point Brands
TPB
$1.56B
| $7.09M | 0.02% |
+144,700
| New | +$6.98M |
|
571
Pebblebrook Hotel Trust
PEB
$2.18B
| $7.02M | 0.02% |
249,061
-701,798
| -74% | -$21.2M |
|
|
GLUU
572
DELISTED
Glu Mobile Inc.
GLUU
| $6.99M | 0.02% |
973,041
+75,742
| +8% | +$696K |
|
573
Nice
NICE
$5.89B
| $6.92M | 0.02% |
50,528
-11,999
| -19% | -$1.62M |
|
574
Viasat
VSAT
$9.77B
| $6.9M | 0.02% |
+85,413
| New | +$7.47M |
|
575
Essent Group
ESNT
$6.23B
| $6.88M | 0.02% |
+146,502
| New | +$6.9M |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.